Research library
Cognitive/peptide

Selank

Canonical identity: Selank

Also indexed as: TP-7

A synthetic peptide studied primarily in limited and region-specific neuropharmacology literature.

Evidence level

Human research, limited or context-specific

Verified against the linked source set on 2026-08-20.

What it is

Selank is a synthetic peptide derived from a tuftsin-related sequence and studied in neurobehavioral and immune-signaling contexts.

Mechanism and research questions

  • Reported research discusses GABAergic, cytokine, and stress-response pathways, but mechanisms are not fully established.
  • The quality and accessibility of the literature vary by study and region.

Human evidence

Human evidence is limited and context-specific; no broadly accepted regulatory pathway was identified in the audit.

Preclinical / mechanistic evidence

Animal and mechanistic studies explore stress, immune, and neurochemical endpoints.

Evidence summary

A literature trail exists, but it does not support broad claims of cognitive or anxiety treatment efficacy.

Limits and interpretation

  • Do not present limited studies as established clinical efficacy.
  • Translation and regulatory status differ by jurisdiction.
  • No dosing or self-experimentation guidance is provided.

Regulatory and identity note

Research-use peptide; not presented as an approved therapy in this catalog.

Research summaries reflect primary literature, patent landscapes, and regulatory status reports at the time of review. They do not constitute therapeutic advice, endorsement, or claims regarding unauthorized preparations.